La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Mesh.i » - entrée « Carbidopa »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Carbamates < Carbidopa < Carbon Monoxide Poisoning  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000081 (1999) C. Dentresangle [France] ; L. Veyre ; D. Le Bars ; C. Pierre ; F. Lavenne ; P. Pollak ; J. Guerin ; J C Froment ; E. BrousolleStriatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study.
000366 (2003) Entacapone/levodopa/carbidopa combination tablet: Stalevo.
000517 (2005) Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
000948 (????) A. Annic [France] ; D. Devos ; D. Seguy ; K. Dujardin ; A. Destée ; L. Defebvre[Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
000959 (1991) P. Joly [France] ; A. Lampert ; E. Thomine ; P. LauretDevelopment of pseudobullous morphea and scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.
000F20 (2013) Hélène Pouclet [France] ; Pascal Derkinderen ; Thibaud LebouvierFoot dystonia heralding levodopa-induced dyskinesias in Parkinson disease.
001097 (2013) Olivier Rascol [France]Extended-release carbidopa-levodopa in Parkinson's disease.
001284 (2014) Olivier Rascol [France]Jejunal levodopa infusion in Parkinson's disease.
001679 (1989) P. Rondot [France] ; M. Ziegler ; N. Aymard ; A. TeinturierEffect of controlled-release carbidopa/levodopa on motor performance in advanced Parkinson's disease.
001C41 (1988) D. Bentué-Ferrer [France] ; H. Allain ; J M Reymann ; O. Sabouraud ; J. Van Den DriesscheLack of pharmacokinetic influence on levodopa by bromocriptine.
001C46 (1987) J L Montastruc [France] ; P. Celsis ; A. Agniel ; J F Demonet ; B. Doyon ; M. Puel ; J P Marc-Vergnes ; A. RascolLevodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Carbidopa" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Carbidopa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Carbidopa
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024